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Nephrotoxicity has become an important public health problem following highly active 
antiretroviral therapy (HAART), and there is paucity of literature reporting the attenuating influence 
of plant based adjuvants that can mitigate the effects. The study investigates the role Hypoxis 
hemerocallidea (H. hemerocallidea) extract following HAART in an experimental animal model. 
Materials and Method:  
Sixty- three adult male Sprague-Dawley rats were used for the study and were divided into 9 groups 
(A-I). Group A received HAART cocktail (Lamivudine, Stavudine & Nevirapine), Group B 
received HAART and H. hemerocallidea extract (100 mg/kgbw), Group C received HAART and H. 
hemerocallidea extract (200 mg/kgbw), Group D received HAART  and vitamin C, Group E 
received HAART and vitamin E, Group F received HAART, vitamin C and vitamin E, Group G 
received H. hemerocallidea extract (100 mg/kgbw), Group H received H. hemerocallidea extract 
(200 mg/kgbw), and Group I received water as placebo. The experiment lasted for 56 days after 
which, the animals were sacrificed, the kidneys were harvested and prepared for haematoxylin and 
eosin (H&E) histological examination and blood samples were collected through cardiac puncture 
and centrifuged to get the serum for blood urea nitrogen and serum creatinine analyses. 
Results:  
Kidney weight changes were not significant except for group A that recorded a significant increase 
(p<0.05) and group B that recorded lowest body weight when compared with the control. Organ-
body weight ratios were significantly higher in group A and group F (p<0.05). 
Adjuvant treatment with H. hemerocallidea (in groups B and C) with HAART resulted in increased 
organ-body ratio, but however not significant. Serum Creatinine (SCR) and blood urea nitrogen 
(BUN) levels were statistically elevated in HAART-treated animals (p<0.05, 0.001). SCR levels in 
group D was significantly reduced (p<0.05) but however, significantly elevated in groups B, C, G 
and H (p<0.001). Groups B and C, as well as groups F and H resulted in higher BUN values 
(p<0.05). The histological appearance of group A was highly compromised. When treated 
concomitantly with H. hemerocallidea (at both dosages), no attenuating influence was seen. 
However, low dose of H. hemerocallidea showed improved histological layout as compared to the 






Adjuvant treatment with H. hemerocallidea extract did not attenuate the nephrotoxicity of HAART 
in this model. 


















1.1      Background 
It is estimated that about 35 million people are living with the human immunodeficiency virus 
(HIV) worldwide in 2013, and more than 25 million people have died from acquired immune 
deficiency syndrome (AIDS) since the first cases were reported in 1981. Most of these deaths are 
due to inadequate access to HIV prevention, care and treatment services (WHO and UNAIDS, 
2015). Adolescents aged between 15 to 49 years account for an estimated 12 per cent of HIV 
infections globally (UNAIDS, 2013).    
The toll of HIV/AIDS continues to be harsh in sub-Saharan Africa particularly Southern Africa. In 
2013, the region accounted for the vast majority of people living with AIDS. The pandemic killed 
an estimated 1.5 million people in 2013 of which 1.1 million of the cases were from sub-Saharan 
Africa (UNAIDS, 2013).   
In 2013, UNAIDS estimated that 12% of the South Africa's population of 48 million had 
HIV/AIDS. The rising prevalence rate increased from 10.6% in 2007 to 12% in 2008, and in 2010, 
an estimated 280,000 South Africans died of HIV/AIDS (UNAIDS, 2013). The Human Sciences 
Research Council, a South African institution, estimates that between 42% and 47% of all deaths 
among South Africans were caused by HIV/AIDS (UNAIDS, 2013). Currently, approximately 6 
million South Africans are living with HIV/AIDS with over 2 million on antiretroviral treatment 
(Shisana et al., 2014). A 2008 study revealed that HIV/AIDS infection in South Africa is distinctly 
divided along racial lines: 13.6% of black Africans in South Africa are HIV-positive, whereas only 
0.3% of whites living in South Africa have the disease (UNAIDS, 2013). 








Table 1.1: Prevalence of HIV infection and estimated death rates by regions (for 
ages 15-49). 






Global Total 35.0 million 1.5 million 0.8 
Sub-Saharan 
Africa 
24.7 million 1.1 million 4.7 
Asia and the 
Pacific 





2.3 million 27000 0.3 
Latin America 1.6 million 47000 0.4 
Eastern Europe 
and Central Asia 
1.1 million 53000 0.6 
Caribbean 250,000 11000 1.1 
Middle East and 
North Africa 
230,000 15000 0.1 
 
 









HIV/AIDS has become one of the world’s most serious health and development problem 
necessitating a global effort mounted to address the epidemic, particularly in the last decade.  The 
number of people infected with HIV has also reduced due to created awareness campaigns and 
introduction of antiretroviral therapy (UNAIDS, 2013). 
The introduction of antiretroviral therapy (ART) for the management of HIV and AIDS 
significantly increased the life expectancy among HIV-infected patients. Between 1996 and 1999 
the advent of highly active antiretroviral therapy (HAART) dramatically improved the survival of 
patients with HIV infection with unprecedented changes in disease progression and mortality seen 
first in the United States and European populations (Palella, 1998; Pezzotti, 1999). The World 
Health Organization (WHO) and other organizations are providing countries with ongoing 
guidance, tools and support in delivering and scaling up ART for HIV/AIDS within the public 
health sector. 
The goal of HAART is to suppress viral replication but its major disadvantage is the adverse side 
effects accompanying its use. HAART toxicity has emerged as a serious complication and 
eventually a major reason for possible discontinuation or changes in treatment limiting patient’s 
adherence and therefore, virologic effectiveness (d’Arminio et al., 2000). Acute drug toxicities still 
exist, and they can affect the quality of life and the patients’ willingness to adhere to their treatment 
regimens (Montessori et al., 2004).  This has also led to further push for less toxic, and easy to 
adhere-to- single tablet monotherapy (Saag and Kilby, 1999). 
The most common and troublesome toxicities of HAART includes hepatotoxicity (Abrescia et al., 
2005; Soriano et al., 2008) which is  linked to mitochondrial damage especially in patients treated 
with zidovudine, stavudine or didanosine (Walker et al., 2004), anaemia and metabolic disorders 
especially with protease inhibitors (Sattler et al., 2001), nephrotoxicity especially with nevirapine or 
tenofovir (Wyatt et al., 2009). 
The kidneys have important physiological functions including maintenance of water and electrolyte 
balance, secretion of hormones and excretion of waste products from the body. In addition, the 
kidneys also play a role in the excretion of drugs and xenobiotic, and hence may be exposed to high 
concentrations of drug metabolites making it liable to drug toxicity (Bentley et al., 2010).  It is 
therefore not a surprise that drug-induced renal injury contributes up to 25% of all cases of acute 
renal failure (Bentley et al., 2010). Drug-induced renal injury may cause cumulative dose-




al., 2010). Renal injury may occur in various renal compartments such as the renal vascular supply, 
the glomerulus, the collecting ducts, the tubulointerstitium where extensive tubular-peritubular 
capillary exchange of solutes takes place (Perazella, 2009). 
During the process of metabolism, a lot of waste materials are produced in the tissues. Apart from 
these, the residue of undigested food, drugs, toxic substances and other pathogenic organisms like 
bacteria are also present in the body. All these substances must be removed to keep the body in a 
healthy condition. Although various organs in the body are involved in performing these functions, 
their excretory capacity is limited. The kidney has the maximum capacity of excretory function and 
so it plays the major role in homeostasis (Sembulingam, 2006). 
 
1.1.1      Gross anatomy of the kidney 
The kidneys are bilateral, bean-shaped excretory organs in vertebrates. In humans, the kidneys are 
located on the posterior abdominal wall in retro-peritoneal position with the right kidney slightly 
lower than the left due to the asymmetry within the abdominal cavity caused by the liver. The right 
kidney sits just below the diaphragm and posterior to the liver while the left kidney is below the 
diaphragm and posterior to the spleen. Each adult kidney weighs between 125 and 170g in males 
and between 115 and 155g in females. The left kidney is usually slightly larger than the right kidney 
(Glodny et al., 2009). 
Resting on top of each kidney is the adrenal gland. The upper  parts of the kidneys are partially 
protected by the eleventh and twelfth ribs, and each whole kidney and adrenal gland are surrounded 
by two layers of fat (the perirenal and pararenal fat) as well being covered by the renal fascia (Clapp 
et al., 2009). 
Internally, the kidney is divided into the outer cortex and inner medulla. The medulla further divides 
into triangular shaped structures called the renal pyramids. The tip of each pyramid empties urine 
into a minor calyx; minor calyces empty into major calyces, and major calyces empty into the renal 









Figure 1.1: Schematic diagram showing coronal section of the right kidney (Adapted from  
www. Ivyroses. com/Human Body/.../Urinary_System_Kidney_Diagram). Assessed 











1.1.1.1     Kidney of other animals 
The kidney of fish, amphibians, reptiles, birds and mammals show increasing sophistication in 
conservation of water and minerals. The kidneys of fish and amphibians are typically narrow, 
elongated organs, occupying a significant portion of the trunk. The collecting ducts from each 
cluster of nephrons usually drain into an archinephric duct (Walter, 2004).  
The kidneys of reptiles consist of a number of lobules arranged in a broadly linear pattern. Each 
lobule contains a single branch of the ureter in its center, into which the collecting ducts empty. 
Reptiles have relatively few nephrons compared with other amniotes of a similar size, possibly 
because of their lower metabolic rate (Romer et al., 2000). 
Birds have relatively large, elongated kidneys, each of which is divided into three or more distinct 
lobes. The lobes consist of several small, irregularly arranged, lobules, each centered on a branch of 
the ureter. Birds have small glomeruli, but about twice as many nephrons as similarly sized 
mammals (Romer et al., 2000).  
1.1.1.2     The rat kidney 
The rat kidneys are located ventrolateral to the vertebral column in the retro-peritoneum just like in 
humans and other mammals (Glodny et al., 2009). 
Each rat kidney has a convex and a concave surface. The renal hilum lies in the concave surface and 
is the point where the renal artery enters the kidney and the renal vein and ureter exit (Bachmann et 
al., 1998). 
Internally, the parenchyma of the rat kidney is divided into two areas: the outer cortex and the inner 
medulla. The cortex extends into the medulla dividing it into triangular shapes known as renal 
pyramids. The renal pyramids contain the renal corpuscles and the convoluted tubular segments 
(Bachmann et al., 1998). 
Each adult rat kidney contains roughly 30000-35000 nephrons. The nephron begins in the cortex 
with the renal corpuscle. The corpuscle consists of a capillary tuft (glomerulus) which is pushed 
into a blind expansion of the Bowman’s capsule. The tubular part of the nephron consists of the 
proximal convoluted tubule, the loop of Henle and the distal convoluted tubule (Bachmann et al., 
1998). According to the location of the corpuscles in the cortex, the nephrons can be distinguished 




of the loop of Henle the nephrons of the rat kidney may be subdivided into two different types: 
nephrons with short loops and nephrons with long loops (Bachmann et al., 1998). 
The rat kidney is fairly typical of mammalian kidneys. It is only in mammals that the kidney takes 
on its classical "kidney" shape, although there are some exceptions, such as the multilobed 
reticulate kidneys of cetaceans (Romer et al., 2000).   
Distinctive features of the mammalian kidney include the presence of the renal pelvis and renal 
pyramids, and of a clearly distinguishable cortex and medulla as shown in figure 1.1. 
1.1.2     Embryology of the mammalian kidney 
The mammalian kidney develops from intermediate mesoderm, proceeds through a series of three 
successive phases, each marked by the development of a more advanced pair of kidneys: the 
pronephros, mesonephros, and metanephros (see figure 1.2) (Bruce, 2004).  
The pronephros develops at the beginning of the fourth week of intrauterine life (IUL) and is 
represented by 7 to 10 solid cell groups in the cervical region. These groups form vestigial excretory 
units, called nephrotomes that regresses before more caudal ones are formed. By the end of the 
fourth week of IUL, all indications of the pronephric system have disappeared (Sadler, 2003).  
The mesonephros and mesonephric ducts are derived from intermediate mesoderm from upper 
thoracic to upper lumbar segments. Early in the fourth week of IUL, during regression of the 
pronephric system, the first excretory tubules of the mesonephros appear. They lengthen rapidly, 
form an S-shaped loop and acquire a tuft of capillaries that will form a glomerulus at their medial 
extremity. Around the glomerulus the tubules form Bowman’s capsule and together these structures 
constitute a renal corpuscle. Laterally the tubule enters the longitudinal collecting duct known as the 
mesonephric or Wolffian duct (Sadler, 2003). 
The metanephros or permanent kidney appears in the fifth week of IUL. Its excretory units develop 
from metanephric mesoderm in the same manner as the mesonephric mesoderm. The collecting duct 
of the metanephros develops from the ureteric bud, an outgrowth of the mesonephric duct close to 
its entrance to the cloaca. The bud penetrates the metanephric blastema which is molded over its 
distal end as a cap. Subsequently the bud dilates forming the primitive renal pelvis and splits into 
cranial and caudal portions, the future major calyces. Each calyx forms two new buds while 




of tubules have formed. Meanwhile at the periphery more tubules form until the end of the fifth 
month of IUL. The tubules of the second order enlarge and absorb those of the third and fourth 
generations forming the minor calyces of renal pelvis. During further development, collecting 
tubules of the fifth and successive generations elongate and converge on the minor calyx forming 















Figure 1.2:  Schematic illustration of the embryology of the mammalian kidney (Adapted from 
Sadler, 2003). 
A. Relationship of the intermediate mesoderm of the pronephric, mesonephric, and 
metanephric systems. In cervical and upper thoracic regions intermediate 
mesoderm is   segmented; in lower thoracic, lumbar, and sacral regions it forms a 
solid, unsegmented mass of tissue, the nephrogenic cord. The longitudinal 
collecting duct is formed initially by the pronephros but later by the mesonephros.  










1.1.3     Histology of the kidney 
Microscopic anatomy of the kidney shows that it is composed of interstitial cells and functional 
units called the nephron. Each nephron consists of tufts of anastomosing capillaries called the 
glomeruli, formed from the afferent arteriole and draining into the efferent arteriole and a tubular 
system called the renal tubule. Epithelial cells called podocytes (or visceral epithelium of Bowman's 
capsule) invest the glomerulus.  
The Bowman's capsule is the distended end of the tubular system and is invaginated by the 
glomerulus (see figure 1.3). The space between the glomerulus and Bowman’s capsule is the 
urinary space. Extending from the capsule is the proximal tubule which is lined by cuboidal and 
columnar epithelial cells containing many mitochondria and a prominent brush border (Walter, 
2004).   
The proximal convoluted tubule is the longest portion of the tubular system and is made up of 
convoluted proximal and distal straight (pars recta) segments. The pars recta descend into the 
medulla where it forms the U-shaped loop of Henle. The loop of Henle re-enters the cortex within 
which it forms the straight and convoluted segments of the distal tubule (see figure 1.4). 
The distal tubule runs close to the glomerular hilum and forms a specialized segment called the 
macula densa. The distal tubule is lined by cuboidal epithelium that lacks a brush border (Walter, 
2004). The distal tubule empties into collecting tubules which in turn drain into collecting ducts. 
The collecting duct converges as they approach the medulla to form the collecting ducts of Bellini 
which run vertically through the medulla to the papillae. The collecting tubules and ducts are lined 
by pale-staining, cuboidal epithelial cells (see figure 1.3).  
The interstitium is made up of the interstitial cells which consist of fibroblast-like cells, lipid-laden 
interstitial cells, macrophages, interstitial dendritic cells and perivascular cells. The fibroblast-like 
cells are mainly located in renal cortex and medulla, and have long cytoplasmic processes forming a 
reticular network between the tubules and capillaries. In the cortex, the interstitium is small and 
mainly occupied by small blood vessels. However in the medulla it increases considerably (Al-






Figure 1.3:  Cross section of kidney tissue of Sprague-Dawley rats showing various histological 
structures. H and E stains. 




























1.1.4     Functions of the kidney 
The kidney performs the function of osmoregulation and excretion of subtances through the 
nephron (see figure 1.4) by the following processes: 
1. Filtration of most small molecules from blood to form an ultra-filtrate of plasma. 
2. Selective reabsorption of most of the water and some other molecules from the ultra-filtrate, 
leaving behind excess and waste materials to be excreted. 
3. Secretion of some excretory products directly from blood into the urine. 









Figure 1.4:  Schematic illustration of the structure of the nephron (Adapted from  
www. ivyroses. com/Human Body/.../Urinary_System_Nepbron_Diagram). 










1.2      HIV and AIDS 
HIV belongs to the retrovirus family of viruses. It affects the immune system of infected persons by 
destroying T-lymphocytes cells, which the body relies to fight infection (NASCOP, 2002). When 
HIV enters the body, it infects helper T lymphocytes which display the CD4 receptor binding sites. 
The virus commandiers the genetic material of the host cell, instructing it to replicate and produce 
new viral particles which break free  from the host, destroying the cell in the process and which then 
move on to infect and destroy other new uninfected lymphocytes (WHO and UNAIDS, 2015). 
 There are two distinct serotypes of HIV viruses: type 1 and type 2. The HIV-1 is the primary cause 
of AIDS worldwide while, HIV-2 is found predominantly in West Africa and its vertical 
transmission develops more slowly and milder compared to HIV-1 (Sanders et al., 2007).   
AIDS is the late stage of HIV infection, a condition characterized by destruction of CD4+ T cells 
which help the body fight diseases (NASCOP, 2002). The syndrome was first identified in 1981 
among homosexual men and intravenous drug users in New York and California and after its 
detection evidence of an AIDS epidemic grew shortly after among heterosexual men, women, and 
children in sub-Saharan Africa (CDC, 2009). Although initial infection with HIV can result in flu-
like symptoms, infected persons typically can show no symptoms for many years but as HIV 
replicate in the body, infected persons begin to show signs and symptoms such as shingles, 
tuberculosis, oral or vaginal thrush, herpes simplex virus, and Kaposi sarcoma (WHO, 2009) which 
are a reflection of a weakened immune system or loss of the body’s ability to fight infection.  
 1.2.1     Modes of transmission of HIV and AIDS 
HIV is transmitted when a person is exposed to body fluids infected with the virus, such as blood, 
semen, vaginal secretions, and breast milk. The primary modes of HIV transmission include having 
unprotected sexual relations with an infected person or sharing hypodermic needles or accidental 
pricking by a sharp object contaminated with infected blood. It can also be transferred from an 
infected mother to her baby during childbirth, or through breast-feeding (Milkowski, 2004). 
The presence of HIV infection in individuals can be ascertained only through laboratory tests on 
various body fluids such as blood, plasma, semen or vaginal fluid among others (WHO, 2009). 
Antibodies to HIV are detectable within four to six weeks of infection by commonly employed tests 





1.2.2     Global Prevalence of HIV and AIDS 
HIV/AIDS remains a pandemic and one of the worst to affect humanity over the last century (Oti et 
al., 2013). Since its discovery in the early 1980s, the infection has quickly developed into a 
worldwide epidemic, affecting virtually every nation. In 1999, about 26.2 million people were 
living with the virus. By the end of 2009, it was estimated that 33.3 million people were living with 
the disease, corresponding to a 27% increase (UNAIDS, 2013). By 2005, more than 20 million 
people had died of HIV and AIDS (WHO, 2009). Already, more than 25 million people around the 
world have died of AIDS-related diseases (WHO and UNAIDS, 2015). Globally, about 34% of 
PLWHAs in 2009 reside in 10 countries in southern Africa; 31% of new HIV infections in the same 
year occurred in these 10 countries, and about 40% of all adult women with HIV live in southern 
Africa (UNAIDS, 2013). These are staggering data that impacts negatively on the socio-economic 
indices in these countries.    
1.2.3     Prevalence of HIV and AIDS in Africa 
The HIV pandemic has continued to challenge the development and economy of many countries in 
Africa and has overwhelmed the health-care systems, increased the number of orphans and caused 
life expectancy rates to reduce.  It is one of the single most important health issues threatening the 
survival of millions of infected people in sub-Saharan Africa (Suave et al., 2002). 
Its impact has been most severe in some of the poorest countries in Africa. At the end of 2009, there 
were 9 countries in Africa where more than one tenth of the adult population aged 15-49 years was 
infected with HIV (UNAIDS, 2013). For instance, in some countries in the southern part of the 
continent, including Botswana, Lesotho, Swaziland, Zimbabwe and South Africa, more than 30 
percent of the populations have HIV infection or AIDS (CDC, 2009). In Kenya, about 2.3 million 
people live with HIV/AIDS and each year, approximately 200,000 Kenyans develop the AIDS 
syndrome (Milkowski, 2004).  
HIV/AIDS pandemic affect all regions and communities and it impacts negatively on households 
and the economic growth of nations. Sub-Saharan Africa is more heavily affected by HIV/AIDS 
than any other region of the world.  In 2008, it was home to two thirds (67%) of all PLWHAs and 
nearly three quarters (72%) of AIDS-related deaths occurs in this region (WHO and UNAIDS, 
2015).   It has ‘sapped’ the population of young men and women in their productive years who form 




proportions in some parts of the world already burdened by war, political upheaval, or unrelenting 
poverty. 
There is increasing evidence that HIV infection of the kidneys is involved with HIV- associated 
nephropathy (HIVAN) (Winston et al., 1999), with studies suggesting that combination 
antiretroviral therapy reduces the incidence of HIVAN, possibly by slowing the decline in renal 
function such that early stages of renal dysfunction are silent and only detectable through laboratory 
analyses (Szczech et al., 2004). 
1.2.4     Management of HIV and AIDS- Antiretroviral therapy 
Whereas no medical treatment can cure AIDS, ART was developed for the management of HIV and 
AIDS to reduce viral load and thus improve longevity. The primary goal of ART is suppression of 
plasma viral load, preservation and restoration of immunologic function, improvement of quality of 
life and reduction of HIV related morbidity and mortality (NASCOP, 2002). Early in the 1980s 
when the HIV/AIDS epidemic began with no visible medical therapy known to reduce viraemia, 
people with AIDS were not likely to live longer than a few years (Carcelain et al., 1999). UNAIDS 
estimated that a total of 2.5 million deaths have been averted in low and middle-income countries 
since 1995 due to the roll out of antiretroviral therapy (UNAIDS, 2013). In other words, HIV/AIDS 
is no longer a ‘death penalty’ for victims. 
The therapy entails the use of antiretroviral medications that attack the virus itself plus other non-
antiretroviral medications to prevent and treat opportunistic infections (OIs) that can occur when the 
immune system is compromised by the virus (WHO, 2009). Counseling and support mechanisms 
are also done to help infected people deal with emotional and traumatizing repercussions by 
encouraging them to accept living with a disabling and potentially fatal disease. This has proven to 
unlock the declines in transmission of the virus.  
ART consists of drugs from five classes; they are nucleoside reverse transcriptase inhibitors 
(NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), fusion 
or entry inhibitors and integrase inhibitors and are approved by the United States of America Food 
and Drug Administration (FDA).  







Table 1.2: Classification of antiretroviral drugs in use. 
Drug Class Mechanism of action Generic Name  
(Other names and 
acronyms) 
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Source: https://aidsinfo.nih.gov/education.../fact.../fda-approved-hiv-medicines 












1.3      Combination antiretroviral therapy (cART) 
Reports from clinical trials are indicating that monotherapies are not completely effective in 
combating HIV virulence and this is the basis for cART (Saag and Kilby, 1999). 
Recently, the U.S Food and Drug Administration (FDA) approved the combination of 2 or 3 active 
antiretroviral agents - cART, involving two NRTIs or combined with one medication from either 
NNRTIs or PIs class (Montessori et al., 2004) as shown in table 1.3. 
cART is sometimes referred to as highly active antiretroviral therapy (HAART) and it has become 
the standard regimen for the management of HIV positive patients (Montessori et al., 2004). It has 
been effective in suppressing the viral load to undetectable levels resulting in decreased HIV RNA 
levels and CD4 T cell increases in the vast majority of patients (WHO, 2009).  HAART has 
dramatically decreased the number of hospital admissions and AIDS patients have achieved an 
impressive improvement in the quality of life (Palella et al., 1998; Soriano et al., 2008). Many 
people affected by the virus are now living with a manageable chronic condition (Kayode et al., 





















Table 1.3: Possible combination antiretroviral therapy- FDA approved. 
Drug Class Generic Name  
(Other names and 
acronyms) 
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1.3.1     HAART-related adverse effects 
Reduction in mortality and viraemia has been the most outstanding achievement in the global fight 
against HIV/AIDS in both low and middle income countries (De Visser and Grierson, 2002). 
Despite these however, there are concerns related to associated toxicities of HAART which have 
increased (Bodeker et al., 2006).  
Increasingly adverse effects caused by HAART ranges from mild to severe and have been well 
documented in many studies (Hawkins, 2010). Each drug in the HAART combination has its own 
side effects. The three common side effects of HAART are diarrhea, nausea and fatigue (Emery et 
al., 2008). Toxicities like lactic acidosis, hepatic steatosis, progressive neuromuscular weakness, 
dyslipidemia and fat mal-distribution were not recognized until after the drugs had been in use for 
years (Hawkins, 2010). 
HAART side-effects may be transient or may persist throughout therapy and are among the most 
common reasons for switching or discontinuing therapy (Hawkins, 2010).  
Renal dysfunction is a HAART side effect that has been associated primarily with tenofovir 
disoproxil fumarate (TDF) which actively accumulates in the proximal renal tubule (Cihlar et al., 
2001). 
1.3.2     HAART-related kidney injuries 
The kidney plays an important role in the metabolism and excretion of  drugs and this makes it 
liable to various types of injuries such as acute kidney injury (AKI), tubulopathies, chronic kidney 
disease (CKD) and end-stage renal disease that may require renal replacement therapy (Choi et al., 
2009). Clinically, HAART causes various kidney injuries including various electrolyte and acid-
base disorders as well as lactic acidosis. These injuries occur via mechanisms such as direct tubular 
toxicity, allergic reactions and precipitation of insoluble drug crystals within renal tubular lumens 
(Parazella et al., 2010). As a consequence, the side effects of HAART renal injuries have become a 
significant cause for concern.  
HAART nephrotoxic effects accounted for 14% of late-onset AKI episodes, occurring 3 months 
after initiating HAART (Roe et al., 2008).  In a meta-analysis of 17 studies (including 9 randomized 
controlled trials) examining TDF safety, a significantly greater loss of kidney function among the 
TDF recipients compared with control subjects (mean difference in calculated creatinine clearance, 
3.92 ml/min; 95% confidence interval, 2.13–5.70 ml/min), as well as a greater AKI risk (risk 




Like most toxic drugs, oxidative stress mediates most pathophysiological processes especially with 
the use of antiretroviral drugs. The reactive oxygen species (ROS) produced directly act on cell 
components including lipids, proteins and DNA and destroy their structure. The consequence of this 
is oxidative stress and cell death (Azu, 2012). It is hypothesized that this toxicity is the result of 
mitochondrial DNA depletion or direct tubular cytotoxicity similar to that associated with the use of 
adefovir and cidofovir (Gallant and Deresinski 2003; Cihlar et al., 2001). 
1.3.3     Risk factors associated with HAART-related kidney disorder 
Risk factors for kidney disease like hypertension, diabetes mellitus, and other related diseases 
remain significant concerns in HIV patients on HAART (Campbell et al., 2009; Overton et al., 
2009). A number of observational studies have documented TDF associated nephrotoxicity 
following its wide spread use in patients with multiple comorbid conditions (Reid et al., 2008). 
TDF-induced renal toxicity is more likely to occur in HIV patients with preexisting kidney disease 
or poorly controlled HIV disease with longer overall antiviral treatment duration, older patients, 
elevated baseline creatinine concentration, and concomitant administration of other nephrotoxic 
drugs (Crum et al., 2010; Nelson et al., 2008). Combined therapy with TDF and protease inhibitors 
such as ritonavir appears to increase renal toxicity (Zimmermann et al., 2006).  
Conversely, HAART may increase the risk of hypertension, diabetes mellitus, and other metabolic 
complications creating a vicious cycle. The possibility of rhabdomyolysis with pigment-related 
kidney injury should be considered in patients with HIV who develop AKI, particularly if they are 
being treated with zidovudine, didanosine, or integrase inhibitors (Joshi and Liu 2000; Zembower et 
al., 2008; Dori et al., 2010).  
In a study by Wyatt et al., (2006), the major risk factors for AKI and associated mortality included 
severe immunosuppression (CD4 count, <200 cells/mm3) and opportunistic infections. Dehydration, 
alkaline urine, and a previous history of nephrolithiasis appear to be risk factors for atazanavir 
associated kidney stones (Couzigou et al., 2007). The risk factors for hyperlactemia (lactate > 
2mmol/l with or without acidosis) which is common with the drugs like stavudine (d4T) and 
didanosine (ddI) include hypertriglyceridemia, obesity, hepatitis infection, impaired kidney function 
(Murphy et al., 2003; Bonnet et al., 2005). Ritonavir-boosted PIs may have an increased propensity 
of causing renal injury. Approximately 70% of the published cases of TDF-induced nephrotoxic 




ritonavir combination therapy and TDF, which manifests as a decrease in the renal clearance of 
TDF, has been identified (Gupta, 2008).  
TDF is actively taken up into the proximal tubules and secreted into the lumen via multidrug 
resistance-associated protein-4 (Ray et al., 2006). Exposure to TDF showed adverse serious renal 
events and graded elevations in serum creatinine of patients, and it has also been linked to the 
development of proximal tubular dysfunction including Fanconi syndrome (FS), AKI, nephrogenic 
diabetes insipidus (NDI), and severe hypokalemia (Gupta, 2008; Labarga et al., 2009).  
Lamivudine, stavudine, abacavir, and didanosine have also been implicated in case reports of FS 
and NDI (Ahmad et al., 2006). FS caused by tenofovir-induced nephrotoxicity is characterized by 
generalized proximal tubular dysfunction resulting in one or more of the following: bicarbonaturia, 
glucosuria (with normal blood sugar), phosphaturia, uricosuria, aminoaciduria, and tubular 
proteinuria (Labarga et al., 2009). 
A recent study by the Columbia University group demonstrated that TDF nephrotoxicity is 
manifested as toxic acute tubular necrosis targeting proximal tubules (including FS in some cases) 
and manifests in distinctive light microscopic and ultra-structural features of mitochondrial injury 
(Herlitz et al., 2010). Acute interstitial nephritis (AIN) has been described with indinavir, abacavir, 
ritonavir, and atazanavir (Chugh et al., 1997; Krishnan et al., 2000). Abacavir causes renal toxicity 
as part of the systemic clinical syndrome of abacavir hypersensitivity (Mallal et al., 2008). 
1.4      Markers of renal injuries 
Renal damage manifests itself as tubular injury with associated reduction in glomerular filtration 
and patients often develop increased serum creatinine, glycosuria, tubular proteinuria, and low 
serum phosphate (Thompson, 2011).  
Diagnosis of HAART induced adverse effects on the kidney involve performing full renal function 
tests (RFTs), a group of clinical biochemistry laboratory blood assays designed to give information 
about the state of a patient's kidney (Daugas et al., 2005). Indirect renal markers namely serum 
creatinine (SCR) and blood urea nitrogen (BUN), as well as electrolytes; sodium (Na+), potassium 
(K+) and chloride (CL-) are assayed to determine renal function. Serum creatinine levels or 





The functional importance of renal biochemical analytes and their levels are significant in 
diagnosing renal-toxicity. These analytes are summarized below. 
1.4.1      Blood Urea Nitrogen (BUN) 
BUN test measures the amount of nitrogen in the blood that comes from the waste product urea. 
Urea is the major end product of protein metabolism. It is synthesized by the urea cycle in the liver 
from ammonia produced by amino acid deamination. Urea is excreted mostly by the kidneys but 
minimal amounts are also excreted in sweat and degraded in the intestines by bacterial action. 
Determination of blood urea nitrogen is the most widely used screening test for renal function 
(Friedman and Young, 2000). It is used in conjunction with serum creatinine determinations to aid 
diagnosis. 
Elevations in BUN concentration indicates that the kidneys are not working efficiently and  occurs 
in some conditions such as inadequate renal perfusion, chronic nephritis, tubular necrosis, 
glomerulo-nephritis and urinary tract obstruction (Friedman and Young, 2000). 
1.4.2      Serum Creatinine (SCR) 
Creatinine is a chemical waste molecule that is generated from muscle metabolism. Creatinine is 
produced from creatine, a molecule of major importance for energy production in muscles. 
Approximately 2% of the body's creatine is converted to creatinine every day (Rock et al., 1986). 
Creatinine is transported through the bloodstream to the kidneys. The kidneys filter out most of the 
creatinine and dispose of it in the urine. The kidneys maintain the blood creatinine in a normal 
range (0.6-1.3 mg/dl). Creatinine has been found to be a fairly reliable indicator of kidney function 
(Reid et al., 2008). Elevated creatinine level signifies impaired kidney function or kidney disease. 
However, in the early stages of kidney damage, a rise in the serum urea levels usually precedes an 
increase in serum creatinine (Reid et al., 2008).  
1.4.3      Sodium (Na+)  
Sodium is the major extracellular cation and functions in maintaining fluid distribution and osmotic 
pressure. Hyponatremia can be caused by prolonged vomiting or diarrhea, diminished reabsorption 
in the kidney and excessive fluid retention whereas increased sodium level can be caused by 




1.4.4      Potassium (K+)  
Potassium is the major intracellular cation and is critical to neuromuscular cell activity. Some 
causes of decreased K+ levels include reduced dietary intake or excessive loss from the body due to 
prolonged vomiting, diarrhea or increased kidney excretion. Increase K+ levels may be caused by 
dehydration or shock, diabetic ketoacidosis, and potassium retention by the kidneys (Toffaletti and 
Jones, 1984).  
1.4.5      Chloride (Cl-)  
Chloride is the major extracellular anion and serves to regulate the balance of extracellular fluid 
distribution. Common causes of decreased chloride include reduced dietary intake, prolonged 
vomiting, reduced renal reabsorption, as well as some forms of acidosis and alkalosis. Increased Cl- 
values are found in dehydration, kidney failure, some forms of acidosis, high dietary or parental Cl- 
intake, and salicylate poisoning (Toffaletti and Jones, 1984).    
As PLWHA continue to rely on HAART to enhance their quality of life, HAART-related toxicities 
keeps occurring and are encountered by clinicians (Campbell et al., 2009) and there is need to 
tackle this challenge. 
1.5      Interaction of HAART and Plant-based extracts 
Recently, there has been interest in the role of complementary and alternative medicines for the 
treatment of various acute and chronic diseases (Aruoma et al., 2006), and previous studies (Azu et 
al., 2010) support the use of plant-based adjuvants for disease management like diabetes, cancers, 
etc. An estimated 80% of Africans are said to rely on complementary and alternative medicines for 
the management of various pathological conditions (Shah, 2004). For the majority of this group of 
individuals, consultation with traditional health practitioners (THP) is the first call for health 
services (Owen-Smith, 2007).  
The high burden of toxicities associated with HAART has attracted various studies designed to 
accommodate a holistic management approach including the use of traditional medicines. Thus, 
while the use of medicinal herbs, a principal component of traditional medicine, predates the 
emergence of HAART toxicity, there remains a widespread consumption of herbal products for the 




Of the various classes of plants, interest has been focused on medicinal plants with pharmacological 
properties and the Hypoxis hemerocallidea plant has been recognized to possess a wide range of 
pharmacological properties such as: anti-inflammatory, antioxidant, antimicrobial, anticonvulsant 
and anticancer properties (Ojewole, 2006; Steenkamp et al., 2006; Ncube et al., 2012). 
1.6      Hypoxis hemerocallidea 
Hypoxis hemerocallidea (H. hemerocallidea) Fisch. & C.A. Mey popularly called African potato 
belongs to the genus Hypoxis, from the large lily family Hypoxidaceae (Boukes and van de Venter, 
2011). It is one of the most popular herbal remedies consumed among people living with HIV/AIDS 
in South Africa to boost immunity and enhance general well-being (Boukes and van de Venter, 
2012). It is a tuberous, perennial herb with long, strap-shaped leaves and yellow, star-shaped 
flowers as shown in figure 1.5 and 1.6 respectively.  
The broad and slightly hairy leaves of H. hemerocallidea are arranged one above the other to form 
three distinct groups of leaves spreading outwards from the center of the plant, while the bright 
yellow, star-shaped flowers are borne on long, slender stalks (Musabayane et al., 2005).  
The tuberous rootstock (corm) of the H. hemerocallidea is referred to in various local languages as 
Afrika patat (Afrikaans), inkomfe (Zulu) and ilabatheka (Xhosa) (Ojewole et al., 2009).  And is 
widely used in southern African traditional medicine as a remedy for an array of human ailments 
(Owira and Ojewole, 2009). 
1.6.1     Ecology of Hypoxis hemerocallidea plant 
Taxonomically, the H. hemerocallidea plant falls under the star-lily family or Hypoxidaceae, which 
consists of 8 general and 130 species; with 90 of them belonging to Southern Africa (Drewes et al., 
2008).  
This family usually consists of monocotyledonous plants, which are normally found in the savanna 
regions of South Africa, Swaziland, Lesotho, Botswana, Mozambique, Zimbabwe and in North-
Eastern Africa (Drewes et al., 2008; Katerere and Eloff, 2008). In South Africa, H. hemerocallidea 
plant is found growing in the wild areas of the Eastern Cape, KwaZulu-Natal, Gauteng and 
Limpopo provinces. It can also be found in the mountainous areas of South America, Australia, and 
in the coasts of Asia (Drewes et al., 2008). 
 The H. hemerocallidea plant has been described as a stemless, geophytic, perennial herb with large 




tuberous perennial plant that consists of yellow star-shaped flowers, long strap-like leaves (30 cm 
long and 3.2 cm wide), brown tuberous rhizomes or corms (up to 10 cm in diameter or length and 
about a half a kilogram in weight) and lots of adventitious roots that allow them to survive 


















Figure 1.5: Photograph showing the H. hemerocallidea plant (Adapted from Drewes et al., 2008). 
 
Figure 1.6: Photograph showing the H. hemerocallidea corm  






leaves grow back in spring, 
and summer. Its leaves are 
strap- like and grow out of 
false sheath like stem which 
extends downwards into the 
underground corm. 
Six-petal star shaped flower 
hence the name ‘yellow star’. 
The ovary, inferior to the 
flower, is not visible. 
The false stem encloses the 
leaves in a tubular, membranous 
sheath made from the remnants 
of old leaves. 
Numerous, adventitious roots 
grow in concentric circles around 
the upper part of the rhizome. 
The mature vertical rhizome 
grows to 7-10 cm diameters. It is 
a swollen, underground stem, 
whose cut surface is yellow-
orange in colour which turns 
brown with oxidation. When the 
leaves die away in winter, the 
rhizome is able to survive the 
harsh freezing conditions. This 
tuber-like structure must have 
developed as a revolutionary 
storage organ to survive high 




1.6.2     Medicinal uses of Hypoxis hemerocallidea Plant 
The H. hemerocallidea plant has been used in South Africa for medicinal purposes, which includes 
its use as an immune booster in HIV/AIDS treatment (SADC, 2002; Mills et al., 2005). Recently, it 
is also used in most countries world-wide as a medicinal remedy for malignancies and inflammatory 
conditions (Drewes et al., 2008; van Wyk, 2008). The plant has long been used by traditional 
healers to treat a variety of general ailments such as cardiac diseases, impotency and infertility, 
hypertension (Drewes et al., 2008; Katerere and Eloff, 2008). It has been used to also treat diseases 
such as diabetes, bronchitis, sore throat, yuppie flu, chronic viral diseases, haemorrhoids, herpes 
simplex, tuberculosis, and stomach ulcers (Steenkamp et al., 2006; van Wyk 2008; Ojewole et al., 
2009).  
The plant is now used to treat diverse types of cancers and tumors such as the urinary diseases, 
testicular tumors, prostatitis, prostate hypertrophy and benign prostate hyperplasia (BPH) (Abegaz 
et al., 1999; Nair and Kanfer, 2006; Drewes et al., 2008). The plant is also used as a CD4 
lymphocytes stabilizer in cancer and HIV/AIDS patients and as a stimulant of muscular and 
hormonal activities (Mills et al., 2005). Traditionally, H. hemerocallidea is prepared by being cut 
into small cubes which are then boiled for 20 minutes and orally consumed (Nair and Kanfer, 
2006). 
1.6.3      Bioactive components in Hypoxis hemerocallidea corm extract 
1.6.3.1      Hypoxoside and rooperol 
Studies have been done on the Hypoxis hemerocallidea Fisch. & C.A. Mey plant extract by several 
authors; Albrecht et al., (1995) showed that the extracts contained a yellow water-soluble crystalline 
compound named hypoxoside. Hypoxoside is the trivial name for (E)-1, 5-bis-(4’-β-D-
glucopyranosyloxy-3’-hydroxyphenyl) pent-4-en-1-yne, which is a norlingan diglucoside isolated 
from the corms of the Hypoxis plants (Albrecht et al., 1995; Nair and Kanfer 2006).  
When hypoxoxide is exposed to β-glucosidase containing media, it is converted and deconjugated 
into a lipophilic bioactive dicatechol aglucone (rooperol). The enzyme β-glucosidase is mainly 
found in the human gastrointestinal tract (mainly in the large intestines) (Boukes et al., 2008).  
The rooperol compound has been proven to exert growth inhibition properties in 60 human cancer 
cell lines, and these include the breast, colon, uterus, melanoma and non-small cell lung cancer cell 




rooperol may play a role in the mechanisms involved in the maintenance of chromosome structural 
integrity and segregation during mitosis. 
In vivo studies have shown that upon oral ingestion of the plant extract from the corm, the non-toxic 
hypoxide is converted by β-glucuronidase (present in the gastro intestinal system) to form rooperol 
phase 2 metabolites (glucuronidase / sulphates) which are also non-toxic (Smith et al., 1995). 
Research has further shown rooperol to contain antioxidant (radical-scavenging) capabilities 
(Laporta et al., 2007), anti-inflammatory (anti COX-1 and anti COX-2 activities) (Jager et al., 1996 
Ojewole, 2006; Steenkamp et al., 2006), anticonvulsant (Ojewole, 2002; Mahomed and Ojewole, 
2003), anticancer (Drewes et al., 2008), cardio depressant and hypotensive (Ojewole et al., 2006), 
and bronchorelaxant properties (Ojewole et al., 2009). 
1.6.3.2      Phytosterols 
In addition to hypoxoside and rooperol, H.  hemerocallidea Fisch. & C.A. Mey plants also possess 
plant sterols known as phytosterols, which also contribute to the medicinal and therapeutic 
properties of the plant (Boukes et al., 2008). Phytosterols have a structure that closely resembles 
that of the cholesterol molecule. Like cholesterol, phytosterols are mainly found in plant cell 
membranes as membrane stabilizers (Awad and Fink, 2000; Boukes et al., 2008). The most 
commonly known phytosterols are betasitosterol (C29H50O), campesterol (C28H48O) and 
stigmasterol (C29H48O), which are only produced in plants. Phytosterols are therefore only obtained 
by humans through diet, especially from sources like unrefined plant cells, seeds, nuts, legumes, 
cereals, fruit and vegetables (Awad and Fink, 2000; Boukes et al., 2008).  
Experimental studies have shown that phytosterols, particularly β-sitosterol, have anticancer 
activities against several cancer cell lines such as the colon, prostate and breast cancers (Boukes et 
al., 2008). This anticancer property of phytosterols is obtained through multiple mechanisms. The 
protection from cancer by the phytosterols is achieved by the ability of β-sitosterol to affect the 
membrane integral structure and fluidity mainly by altering the phospholipid concentration, the 
cholesterol / phospholipid ratio and the fatty acid composition of cancer cells (Awad and Fink, 
2000).  
Moreover, β-sitosterol stimulates the proliferation of the human peripheral blood lymphocyte 
(human T-cells) (Bouic et al., 1996) and has no effect on estrogen receptors (Awad and Fink, 2000); 
thus β-sitosterol can be used as an immune system booster and also for the management of testicular 




membrane-bound enzymes as well as on the signal transduction pathways. Beta-sitosterol stimulates 
apoptosis in cancer cells by inhibiting cancer cell proliferation and tumor growth (Awad and Fink, 
2000).  The Hypoxis plant contains a combination of β-sitosterol and its glucoside, β-sitosterol 
glucoside. These compounds are known to treat prostate hypertrophy due to their ability to inhibit 
the 5α-reductase and aromatase enzymes in order to inactivate the binding of dihydrotestosterone 
within the prostate gland (van Wyk, 2008).  
In some countries, these phytosterols (because of their capability of lowering both the plasma-
cholesterol and low density lipoprotein (LDL)-cholesterol levels) are now used to treat mild 
hypercholesterolaemia and cardiovascular diseases, pulmonary tuberculosis, HIV and immune 
system suppression (Pegel, 1997). Other important therapeutic properties of phytosterols include 
them being used as anti-diabetic and anti-inflammatory agents (Pegel, 1997). 
1.6.3.3      Lectins 
Studies have shown that the extracts of H.  hemerocallidea Fisch. & C.A. Mey contains lectin-like 
compounds (Gaidamashvili and van Staden, 2002) and cytokinins (Hutchings et al., 1996). Lectins 
are non-enzymatic glycoproteins that reversibly and specifically bind carbohydrate moieties on cell 
membranes (Gurib-Fakim, 2006). Lectins also called agglutinins react with surfaced-exposed 
carbohydrates of microbes and cause lectin-bacteria agglutination reactions to occur (Gaidamashvili 
and van Staden, 2002).  
Due to their high specificity, lectins are used as diagnostic probes for the identification of bacterial 
pathogens as well as for the recognition and differentiation of malignant tumours. Studies on lectins 
have shown that lectins are capable of inhibiting the motility, multiplication and growth of some 
plant bacterial pathogens by agglutinins; thus lectins are perceived as important for plant defence 
system activation (Gaidamashvili and van Staden, 2002; Ghazarian et al., 2011).  
In humans, lectins prevent the adhesion and interaction of bacteria with the epithelial cells of the 
gastrointestinal tract. Lectin agglutinins can interact with enterocytes and lymphocytes in order to 
expose pathogens to body tissues, thus allowing for the activation of an immune response. Lectins 
are also believed to possess some anticancer properties together with apoptosis-inducing capabilities 






1.6.4     Pharmacological activities of Hypoxis hemerocallidea extracts 
1.6.4.1      Anti-inflammatory and anti-diabetic activity 
H.  hemerocallidea Fisch. & C.A. Mey is a well-known remedy for the management and control of 
painful arthritic and inflammatory conditions and also for adult-onset type-2 diabetes. Supporting 
these claims, Ojewole (2006) showed that at a dose of 50–800 mg/kg body weight, oral 
administrations of H. hemerocallidea methanol and aqueous corm extracts significantly inhibited 
egg albumin-induced acute inflammation and also reduce blood glucose levels in both normal and 
streptozotocin-induced diabetic rats in a dose-dependent manner.  
Furthermore, intraperitoneal injections of H. hemerocallidea extracts produced anti-nociceptive 
effects against chemically and thermally-induced nociceptive pain in mice (Ojewole, 2006). 
Researchers (Jäger et al., 1996; Steenkamp et al., 2006; Ncube et al., 2012) demonstrated some 
inhibitory activity against COX-1 and COX-2 enzymes by both the ethanol and aqueous extracts of 
H. hemerocallidea in both in vitro and in vivo models. Neither of the same extracts produced a 
significant inhibition of the two enzymes in vitro even at concentrations as high as 0.5 mg/ml (Jäger 
et al., 1996; Steenkamp et al., 2006; Ncube et al., 2012).  Contrary to these findings, and according 
to Laporta et al., (2007), rooperol showed a noticeable inhibitory effect on both enzymes, with a 
stronger effect on COX-2 than COX-1, yielding a COX-2/COX-1 IC50  ratio of 1.9.  Lectin-like 
proteins purified from aqueous extracts of H.  hemerocallidea inhibit COX-1 enzyme that mediates 
prostaglandin synthesis in vitro (Gaidamashvili and van Staden, 2006). The anti inflammatory 
activity of H.  hemerocallidea extracts are suggested to be more likely taking place via the 
inhibition of the prostaglandins, 5-lipoxygenase pathway and other inflammatory mediators such as 
antioxidant activity which in turn, inhibits COX enzymes (van der Merwe et al., 1993; Steenkamp 
et al., 2006).    
The hypoglycaemic effects of H. hemerocallidea aqueous extracts were investigated on fasted 
normal and diabetic rats, with a dose-dependent (100–800 mg/kg) moderate to high response being 
recorded against insulin (5 mg/kg) and glibenclamide (5 mg/kg) as positive controls (Mahomed and 
Ojewole, 2003; Ojewole, 2006). At a dose of 800 mg/kg, the caused 30.2% and 48.5% reductions in 
the blood glucose concentrations of fasted normal and streptozotocin-treated diabetic rats 
respectively (Mahomed and Ojewole, 2003). They concluded that the extracts could likely induce 
hypoglycaemia by stimulating insulin release thereby enhancing the cellular uptake and utilization 




1.6.4.2      Antioxidant activity 
The aqueous and ethanolic extracts of H.  hemerocallidea demonstrated good antioxidant properties 
through hydroxyl scavenging ability (Steenkamp et al., 2006; Nair and Kanfer, 2007). In vitro 
studies indicate that aqueous extracts of H.  hemerocallidea have good ability to scavenge free 
radicals (hydroxyl ions) (Mahomed and Ojewole, 2003). Rooperol significantly increased reactive 
oxygen species (ROS) and nitric oxide (NO) production, and phagocytosis in undifferentiated and 
differentiated human promonocytic U937 leukaemia cells than its positive control ascorbic acid 
(Boukes and van de Venter, 2012). Using the ferric reducing ability of plasma (FRAP) assay, the 
authors later confirmed the antioxidant capacity of rooperol, results of which were consistent with  
previous studies of  Mahomed and Ojewole (2003), Steenkamp et al., (2006) and Laporta et al., 
(2007).  
In a separate but related study, rooperol reduced quinolinic acid induced lipid peroxidation in rat 
liver homogenates and significantly scavenged the superoxide anion at pharmacological doses (Nair 
et al., 2007). At similar concentrations (8, 16 and 32 mg/ml), rooperol demonstrated significantly 
greater ferric reducing activity than ascorbic acid (Nair et al., 2007) while Boukes and van de 
Venter, (2012) reported similar results at a concentration of 20 mg/ml. Using albino rats, water 
decoction of H.  hemerocallidea corms (10 mg/kg) exhibited good antioxidant activity by inducing 
protection against oxidative stress generated by chloroquine in a dose dependant manner 
(Chaturvedi and Mwape, 2011).  
The bioactive compound rooperol isolated from H.  hemerocallidea has a unique structural 
similarity to nordihydroguaiaretic acid which is a strong antioxidant, a phenomenon that could 
explain the antioxidant properties of these extracts (van der Merwe et al., 1993; Boukes and van de 
Venter, 2012). Using platelet microsomes, rooperol and nordihydroguaiaretic acid gave comparable 
results in the inhibition of leukotriene synthesis in the polymorphonuclear leucocyte and 
prostaglandin synthesis as well as stimulate the oxidation of haemoglobin to a greater extent (van 
der Merwe et al., 1993; Coetzee et al., 1996). 
1.6.4.3      Antimicrobial and antiviral activity 
A number of extracts from Hypoxis species have demonstrated antibacterial, antifungal and antiviral 
activities against numerous pathogenic strains associated with acute infections (Buwa and van 
Staden, 2006; Steenkamp et al., 2006). Evidence-based laboratory investigations indicate that 




pharmacological properties (Owira and Ojewole, 2009). Crude ethyl acetate extracts of H. 
hemerocallidea corms exhibited potent antimicrobial activities against Staphylococcus aureus and 
Enterococcus faecalis using a microdilution assay (Katerere and Eloff, 2008).  
Following a similar test procedure, Ncube et al., (2011) reported water and lipophilic leaf and corm 
extracts of H.  hemerocallidea to have good antibacterial and anticandidal activity in autumn and 
winter against Bacillus subtilis, Escherichia coli, Klebsiella pneumonia and Staphylococcus aureus 
and Candida albicans. A remarkable complete inhibition of Escherichia coli growth at a 
concentration of 100 mg/ml was recorded from aqueous and methanolic extracts of H. 
hemerocallidea (Steenkamp et al., 2006). Excellent agglutination activity against Staphylococcus 
aureus and Bacillus subtilis was reported from lectin-like proteins extracted from H. 
hemerocallidea (Gaidamashvili and van Staden, 2002).  
In a synthetic membrane model study, the compound promoted high membrane leakage in 
Escherichia coli but with a much stronger inhibition on Staphylococcus aureus. The active 
compound rooperol exhibited a high physiological membrane leakage in an Escherichia coli model 
containing synthetic membranes. Inhibition of bacterial growth is through disruption of the 
phospholipid/ water interface through the formation of gel-fluid like intermediate structures with 
isotropic motion in phosphatidyglycerol membranes at physiological pH (Laporta et al., 2007). H. 
hemerocallidea showed interference with the efflux of nevirapine across intestinal epithelial cells 
and potentially increase the bioavailability of this antiretroviral drug when taken concomitantly 
(Brown et al., 2008). 
1.6.4.4      Cardiovascular and anticonvulsant activity 
In a study involving Chacma baboons, Coetzee et al., (1996) established that a purified extract of 
Hypoxis hemerocallidea corms (rooperol) increased myocardial contractility in vivo. Rooperol 
caused moderate, transient increased cardiac output, stroke volume and vascular pressures without 
increased heart rate or filling pressures, suggestive of increased myocardial contractility probably 
allied to its catechol structure (Coetzee et al., 1996).  
Moreover, in their investigation on the effect of the aqueous corm extract of H.  hemerocallidea on 
myocardial contractile performance of guinea-pig isolated atrial muscle strips in vitro, Ojewole et 
al., (2006) reported significant concentration dependent positive inotropic and chronotropic 




reductions in the systemic arterial blood pressure and heart rates of hypertensive rats used in the 
same study (Ojewole et al., 2006).  
In another study, chronic ingestion of aqueous extract of H.  hemerocallidea (as tea) was reported to 
have caused ventricular tachycardia in a 25-year-old male subject (Ker, 2005). The observations 
suggest that H. hemerocallidea corm extracts may contain some active chemical constituents with 
some cardio-stimulatory properties. Aqueous extracts of H. hemerocallidea (50–800 mg/kg) 
significantly delayed (P<0.05–0.001) the onset of, an antagonized pentylenetetrazole-induced 
seizures in mice better than phenobarbitone and diazepam (which are known anticonvulsant 
compounds) (Ojewole, 2008). Stafford et al., (2007) reported ethyl acetate extracts of H. 
hemerocallidea to exhibit moderate non-selective inhibitory effects at IC50 of 25 ± 5µg/ml on 
monoamine-oxidase enzyme which is involved in a number of neurological processes. 
1.6.4.5      Anticancer activity 
Steenkamp and Gouws (2006) found that aqueous extracts of H.  hemerocallidea at 50 mg/ml 
significantly inhibited DU-145 prostate cancer cell growth more than cisplatin, a known anti-tumor 
agent. Albrecht et al., (1995) demonstrated that sitosterols from H. hemerocallidea have good in 
vitro activities by stimulating lymphocyte proliferative responses towards phyto-haemoglutinin at 
very low concentrations, making these compounds essential nutrients to be taken on a daily basis 
for the optimal functioning of the immune system.  
In vitro studies on the compound hypoxoside have been shown to be cytotoxic against cancer cells 
at concentrations of up to 100 mg/ml. However, when hydrolyzed to its aglucone, rooperol, by ß-
3glucosidase, cytotoxicity was found to be ranging from concentrations between 2 and 10 mg/ml 
(Marini-Bettolo et al., 1982). This led to the discovery of the promising potential of H. 
hemerocallidea as an oral prodrug for cancer therapy in humans given its first-pass metabolism into 
non-toxic conjugate rooperol which may be activated in tumor cells with high deconjugase activity 
(Albrecht et al., 1995).  
Evidence of rooperol's activity as an anticancer agent has been further demonstrated using a model 
system consisting of normal, non-invasive breast epithelial cell lines by spontaneous 
immortalization of cells from fibrocystic breast tissue support (Soule et al., 1990; Tait et al., 1990), 
and a premalignant, invasive and tumorigenic derivative, resulting in transfection of the cell line 




In a study by Boukes and van de Venter (2011) to investigate and compare the cytotoxicity and 
mechanisms of action of H.  hemerocallidea extract, the authors concluded that different cell lines 
exhibit different sensitivities towards the plant extract. They determined cytotoxicity of the H. 
hemerocallidea extract against cervical (HeLa), colorectal (HT-29) and breast (MCF-7) cancer cell 
lines as well as peripheral blood mononuclear cells (PBMCs). They also determined DNA cell cycle 
arrest in the Gap 1 synthesis or Gap 2 mitotic phase using propidium iodide staining. They 
concluded that the cytotoxic mechanism of H.  hemerocallidea is exerted through the induction of 
cell cycle arrest and apoptosis (Boukes and van de Venter, 2011). 
1.7       Problem statement 
ART has significantly improved the prognosis of HIV and AIDS infection by reducing 
transmission, viral load and limiting opportunistic infections. This has led to improved wellbeing 
and longevity of people living with HIV/AIDS (PLWHAs). However, ART results in toxicities that 
complicate its management and increases the cost of overall health care. Adverse effects have been 
reported with most antiretroviral drugs and are among the most common reasons for switching 
therapy (O’Brien et al., 2003).  
For instance, nephrolithiasis was seen in up to 27% of patients treated with indinavir and there are 
numerous studies demonstrating that tenofovir is also associated with impaired kidney function 
(Mocroft et al., 2003). Glomerular filtration rate (GFR) correlates with the severity of kidney 
disease and typically decreases before the onset of symptoms of kidney failure (Mocroft et al., 
2003). 
The HAART side effects have become an important public health problem contributing to more 
than 50% of kidney injuries, a fraction of which may require immediate transplantation (Choi et al., 
2009). It is anticipated that as the population of HIV-infected patients start to age and therefore 
remain on HAART for longer period of time, HIV and HAART-related metabolic disorders would 
correspondingly increase. The consequences are quite huge in terms of economic cost and care.  
Jevtovic (2008) observed that the cumulative long-term toxicities of HAART emerge as a 
significant complication to the kidney.  Finding possible mitigating avenues/ treatment options 







1.8      Justification for study 
The problem of drug toxicity continues to attract the attention of researchers both in experiments 
and clinical trials. Evidence shows that animal models of drug toxicity represent a similar pattern in 
humans. For example, one-third of all drugs associated with hepatotoxicity in animals resulted in 
liver enzyme elevation in humans Sulkowski et al., (2004).  
Although, animal models may not always predict human drug toxicities, drug-induced toxicity 
described in clinical trials is often detected long after a drug may have entered the market 
(Sulkowski et al., 2004). Therefore, experimental animal studies serves to investigate whether a 
drug has the potential for toxicity before even being tested in clinical trials.  In this study, the rat 
serves as a suitable model for investigating the mammalian kidney based on its similar structure and 
physiologic functions, while being easy to handle and generally considered less expensive. 
Treatment with cocktail of antiretroviral drugs predisposes People living with HIV and AIDS 
(PLWHAs) to adverse effects. Such cohorts of patients are at high risk of developing short and 
long-term complications such as renal-toxicity, hepatotoxicity, and cardiovascular disorders 
amongst other things (Sanders et al., 2007). 
The associated toxicities of HAART necessitate the need for safe and less costly adjuvants that can 
mitigate these effects. Plant-based extracts have the potential to fill this need. The search for 
medicinal plants has continued to grow due to its easy accessibility, relatively low cost and a 
perceived effectiveness. An increasing reliance on the use of medicinal plants in industrialized 
societies has been traced to the extraction and development of several drugs and chemotherapeutics 
from these plants (Fasinu et al., 2012). The Southern African ecosystem is replete with medicinal 
plants that continue to drive improvement in indigenous knowledge systems.   
It is estimated that about 80% of the general population in sub-Saharan Africa rely on African 
traditional medicines to treat various diseases (Hostetmann et al., 2000). H. hemerocallidea Fisch. 
& C.A. Mey falls into this category and has been widely used for the treatment of various ailments 
within the region and studies have attributed this to the pharmacological properties it possesses 
(Albrecht et al., 1995). 
More so, there has been a surge in commercially available herbal remedies obtained as ‘over- the- 




efficacious against a variety of diseases and as an immune boosters for PLWHAs (Albrecht et al., 

























1.9      Research questions 
i. Does H. hemerocallidea ameliorate kidney injuries following HAART? 
ii. Would vitamins C and E serve as a better antioxidant supplements than H. hemerocallidea 
in HAART-induced renal injuries? 
iii. What is/ are the probable mechanism(s) of HAART induced kidney injuries? 
1.10     Objectives of study 
The objectives of this study are presented in line with two major focus areas: 
a. To assess the histological changes following administration of HAART on the kidney of 
experimental animals and the role of H.  hemerocallidea. 
 
b. To obtain measures of renal function through assay of serum creatinine and blood urea 
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Abstract 
Nephrotoxicity has become an important public health problem following highly active 
antiretroviral therapy (HAART), and there is paucity of literature reporting the attenuating influence 
of plant based adjuvant that can mitigate the effects. The study investigates the role Hypoxis 
hemerocallidea extract following HAART in an experimental animal model. 
Sixty three adult male Sprague-Dawley rats were used for the study and were divided into 9 groups 
(A-I), where group A-H served as the experimental groups while group I served as the control. The 
experiment lasted for 56 days after which, the animals were sacrificed, the kidneys were harvested 
and prepared for H&E histological examination and blood samples were collected through cardiac 
puncture and centrifuge to get the serum for blood urea nitrogen and Serum creatinine analysis.  
Organ-body weight ratios were significantly higher in group A and group F (p<0.05). 
Serum Creatinine (SCR) and blood urea nitrogen (BUN) levels were statistically elevated in 
HAART-treated animals (p<0.05, 0.001). SCR levels in group D was significantly reduced (p<0.05) 
but however, significantly elevated in groups B, C, G and H (p<0.001). Groups B and C, as well as 
groups F and H resulted in higher BUN values (p<0.05). The histological appearance of group A 
was highly compromised. When treated concomitantly with Hypoxis hemerocallidea (at both 
dosages), no attenuating influence was seen. However, low dose of Hypoxis hemerocallidea showed 
improved histological layout as compared to the high dose. Co-administration of HAART and 
combined dose of vitamin C and E did not improve the histoarchitecture. 
Adjuvant treatment with Hypoxis hemerocallidea extract did not attenuate the nephrotoxicity of 






Hypoxis hemerocallidea (H. hemerocallidea) Fisch. & C.A. Mey belongs to the family 
Hypoxidaceae, is widely distributed in the savanna regions of South Africa, Swaziland and 
Zimbabwe and is increasingly also grown as a pot plant. It was previously known as Hypoxis 
rooperi and commonly called the African potato, Lilabatseka, Zifozonke (Swazi) and Inkomfe 
(Zulu) (Drews et al., 2008; van Wyk et al., 2008).  
The H. hemerocallidea is a stemless, geophytic, perennial herb with large corms (tubers) which are 
dark brown to black on the outside and bright yellow inside (van Wyk et al., 2008) with more than 
90 species endemic to South Africa (Fabian and Germishuizen, 1997). The corm of H. 
hemerocallidea has been successfully used to treat some traditional western ailments including 
urinary tract infections, hypertension, a variety of inflammatory conditions, testicular tumors, and 
more recently as immune boosters for HIV-AIDS. Its traditional usage dates back many generations 
(Owira and Ojewole, 2009). There is also anecdotal evidence that the plant can be poisonous (Ker, 
2005). 
The corm of H. hemerocallidea has been exploited in a variety of ways; dietary/herbal, traditional 
and pharmaceutical purposes (Awad and Fink, 2000). The  Hypoxideae  family especially the H. 
hemerocallidea is noted for the occurrence of a hypoxide which is a secondary  metabolite of the 
plant (Nair et al., 2007; Drews et al., 2008) that is hydrolysed into rooperol  (which is the active and 
powerful antioxidant component of the corm) (Laporta et al., 2007). Rooperol is also been reported 
to be anticarcinogenic against the mouse model BL6 melanoma (Albrecht et al., 1995).  
Extracts of H. hemerocallidea corms have been ingested by man as a dietary supplement hence used 
for its nutritional value. With increasing interest in the use of phytosterols for the reduction of 
serum cholesterol and for immune boosting, there has been a resultant increase in scientific 
investigations (Moreau et al., 2002) surrounding these benefits. More so, there has been a surge in 
commercially available herbal remedies obtained as ‘over- the- counter’ medicines containing 
sterols with H. hemerocallidea extract enrichments claimed to be efficacious against a variety of 
diseases. 
However, the scientific validation of these claims remains to be verified despite its anti-
inflammatory, antimicrobial, anticonvulsant and anticancer properties that various authors (Ojewole 





The significant achievements in reduction in morbidity and mortality following the intervention 
with highly active antiretroviral therapy (HAART) on HIV/AIDS epidemic has led to a dramatic 
step that improved longevity of people living with HIV/AIDS (PLWHAs). Despite these positive 
achievements, associated HAART-induced organ toxicities continue to accumulate thus dampening 
the perceived impacts (Bodeker et al., 2006).  
The most common and troublesome toxicities of HAART includes hepatotoxicity (Abrescia et al., 
2005; Soriano et al., 2008) linked to mitochondrial damage especially in patients treated with 
zidovudine, stavudine or didanosine (Walker et al., 2004), anaemia and metabolic disorders 
especially with protease inhibitors (Sattler et al., 2001), nephrotoxicity especially with nevirapine or 
tenofovir (Wyatt et al., 2009).  HAART-induced kidney injuries could manifest in electrolyte and 
acid-base imbalance as well as lactic acidosis and occur via mechanisms that target direct tubular 
toxicity, allergic reactions and precipitation of insoluble drug crystals within renal tubular lumens 
(Parazella et al., 2010).  
Like most toxic drugs, oxidative stress mediates most pathophysiological processes especially with 
the use of antiretroviral drugs. The reactive oxygen species produced directly act on cell 
components including lipids, proteins and DNA and destroy their structure. The consequence of this 
is oxidative stress and cell death (Azu, 2012).  
We hypothesis that the oxidative stress-induced HAART renal injuries can be mitigated by adjuvant 
treatment with extracts of H. hemerocallidea due to the rich antioxidative properties. Therefore, our 
study will investigate the role of adjuvant use of AP in HAART protocol on renal architecture in 











Materials and methods 
Chemicals/drugs  
Lamivudine (3TC), stavudine and nevirapine (Aspen) and vitamin C (L-ascorbic acid) were bought 
from Pharmacare Ltd, Port Elizabeth, South Africa and of analytical grade. Vitamin E solution was 
obtained from Kyron Prescription CC, Benrose, Johannesburg, South Africa. 
Plant  
Fresh corms of H. hemerocallidea were purchased from a local ‘Muthi’ in Umbilo Road, Durban, 
KwaZulu-Natal, harvested in July, 2014. The corms were taken to the herbarium unit of the 
Department of Life Science, Westville Campus, University of KwaZulu-Natal, Durban South Africa 
and were authenticated by Prof. Ashley Nicholas. Sample of it was retained at the herbarium for 
future reference. 
Preparation of corm aqueous extract  
H. hemerocallidea fresh corms were extracted according to the procedure of Ojewole et al., 2009. 
They were washed with water, cut into smaller pieces, air- dried at room temperature (25-280C) and 
ground into fine particles in a commercial blender.  
The grinded corm was soaked in hot distilled water and extracted twice, on each occasion with 2.5 
litres of hot distilled water (at 90–100 0C) for 12 hours. The combined extract, were concentrated to 
dryness under reduced pressure in a rotary evaporator at 70 ± 1 0C. The resulting crude aqueous 
extract was freeze- dried, finally giving off a dark brown, and powdery aqueous extract residue 
(170.5 g, 85.25 % yield). Without any further purification, aliquot portions of the aqueous extract 
residue were weighed and dissolved in distilled water (at room temperature) for use on each day of 
our experiments. 
Animal treatment and experimental design  
Sixty- three adult male Sprague-Dawley rats weighing between 261-310 g were used for this study. 
The animals were bred and maintained at the Animal House of the Biomedical Resources Unit, 
University of KwaZulu-Natal, South Africa. The animals received humane care in accordance with 
the Principle of Laboratory Animal Care of the National Medical Research Council and the Guide 
for the Care and Use of Laboratory Animals of the National Academy of Sciences (National 




KwaZulu-Natal Animal Ethics Committee and assigned reference number: 100/14/Animals. The 
investigation was carried out at the Biomedical Research Unit Animal housing facility.   
All the rats were housed in well ventilated plastic cages (7 rats per cage) having dimensions of (52 
cm long × 36 cm wide and 24 cm high). They were maintained under standardized animal house 
conditions (temperature: 28–31 °C; light: approximately 12 h natural light per day) and were fed 
with standard rat pellets from (Meadow feeds a Division of Astral Operations Limited, Durban, 
South Africa) and given tap water ad libitum.  The animals were randomly distributed to nine 
treatment groups: A, B, C, D, E, F, G, H, I with seven animals per group.  
Group A:  HAART (a cocktail of Lamivudine, Stavudine and Nevirapine) using the human 
therapeutic dose equivalents (mg/day for Lamivudine, Stavudine and Nevirapine respectively) 
administered as a daily dose (Azu et al., 2014).  
Group B received HAART and AP extract (100 mg/kgbw),  
Group C received HAART and AP extract (200 mg/kgbw),  
Group D received HAART and vitamin C (250 mg/kgbw),  
Group E received HAART and vitamin E (40 mg/kgbw; Bansal et al., 2005), twice a week for the 8 
weeks, 
 Group F received combination of HAART, vitamin C and vitamin E, 
Group G received AP extract alone (100 mg/kgbw), 
Group H received AP extract alone (200 mg/kgbw), 
Group I served as the control administered 0.9 % normal saline.  
All administration was done daily by oro-gastric gavage except for vitamin E which was 
administered intramuscularly. At the end of the treatment period (56 days), the animals were killed 
24 hr after the last treatment under excess Halothane®anaesthesia. 
Body and kidney weight  
Body weights of animals were recorded on the first day before treatment (initial), thereafter weekly 
and on the day of sacrifice (final). Kidney weight (KW) was measured by an electronic balance 
(Mettler Toledo; Microsep (Pty) Ltd., Greifensee, Switzerland).  
Histological examination of tissues 
Twenty four hours after the last treatment, the animals were given humane sacrifice under excess 




pathology and immediately fixed in 10% Neutral buffered saline. After proper fixation, the tissues 
were dehydrated in graded series of alcohol, cleared in Xylene and embedded in paraffin wax using 
a cassette. The tissues were sectioned at 4 µm thickness using Leica RM 2255 microtome and 
stained with haematoxylin and eosin. The stained slides were cover slipped using DPX mounting 
glue directly over the tissue section ensuring no air bubbles were trapped. Thereafter, the slides 
were left overnight to dry for examination under light microscope. The sections were examined 
using a binocular Olympus microscope coupled with digital image camera Nikon Eclipse 50i, 
Tokyo, Japan (used to acquire the images). An independent histopathologist blinded to the treatment 
groups reported on the qualitative assessment of the slides. 
Assessment of kidney function 
Blood samples were collected through cardiac puncture and allowed to cloth for 30 minutes and 
centrifuged for 15 minutes at 3000 revolutions per minute. The serum was decanted into Eppendof 
tubes and prepared for analysis of blood urea nitrogen (BUN) and serum creatinine (SCR) using 
Beckman Coulter Synchron® system(s) BUN and SCR assay kit. 
Beckman Coulter Synchron® system BUN assay kit and Beckman Coulter Synchron® system SCR 
assay kit were bought from Global Viral Laboratory, Durban, South Africa for the assessment of 
BUN and SCR levels. 
Statistical analysis 
Continuous variables (kidney and body weight, BUN and SCR levels), were analyzed by one–way 
analysis of variance (ANOVA) followed by Dunnett’s multiple comparison post-test using Graph 
pad prism ® statistical software 5.02. The results are expressed as mean ± SD (standard deviation). 
Values were considered significant at p <0.05. 
Results 
Mortality: No animal died during the experimental period. 
Body weight and organ (kidney) weight changes 
The final body weights of rats were in all groups  higher than the initial weight but the percentage 
gain was maximal in group D (HAART with vitamin C), then groups H, G all recording 48.66 %, 




HAART +AP 100mg/kg (table 1). Similarly, kidney weight changes were not significant except for 
group A that recorded a significant increase (p<0.05) and group B that recorded lowest body weight 
when compared with the control. Organ-body weight ratios were significantly higher in HAART 
treated animals and HAART with vitamins C and E (p<0.05) compared to other groups. Whereas  
group E (HAART and vitamin E) and group G (H. hemerocallidea 100 mg/kg) did not show any 
increase in organ-body weight ratios as compared to control (table 1). Group H animals treated with 
H. hemerocallidea 200 mg/kg showed significant reduction (p<0.05) in organ-body weight ratios.  
Co-administration of H. hemerocallidea (at both dosages) with HAART resulted in increased organ-
body ratio, however not significant.  
 
Table 1: Body weight, kidney weight and KW/BW ratio of experimental and control groups 





KW (g) KWBR 
A 311·43 ± 3·36 427·00 ± 9·94 115·57  37·11 2·48 ± 0·19 0·58* 
B 279·57 ± 7·16 363·14 ± 11·50 83·57  29·89 2·06 ± 0·26 0·57 
C 281·57 ± 2·88 382·71 ± 5·52 101·14  35·92 2·17 ± 0·12 0·57 
D 261·00 ± 7·49 388·00 ± 8·28 127·00  48·66 2·17 ± 0·14 0·56 
E 271·57 ± 7·14 359·71 ± 12·31 88·14  32·46 1·93 ± 0·24 0·54 
F 273·00 ± 6·29 371·86 ± 18·43 98·86  36·21 2·16 ± 0·33 0·58* 
G 256·71 ± 8·65 369·86 ± 12·66 113·15  44·08 1·99 ± 0·26 0·54 
H 260·00 ± 6·06 381·00 ± 11·21 121·00  46·38 2·03 ± 0·15 0·53* 
I 285·86 ± 3·80 407·29 ± 3·69 121·43  42·48 2·18 ± 0·45 0·54 
Values are expressed as mean ± SD for each group and considered statistically significant at 
p<0.05*. BW= body weight of rats, KW= kidney weight of rats, KWBR= kidney weight body ratio. 
SCR and BUN and levels 
Functional nephrotoxicity indices such as blood urea nitrogen (BUN) and serum creatinine (SCR) 
were statistically elevated in HAART-treated animals (p<0.05, 0.001) compared with the control. 
Adjuvant treatment with H. hemerocallidea (at both dosages) with HAART, as well as co-treatment 
with vitamins C and E and HAART as well as H. hemerocallidea 200mg/kg resulted in higher BUN 




(p<0.05) when compared with the control. Similarly, SCR values were significantly elevated in 
groups B, C, G and H (p<0.001) (table 2). 
 
Table 2: Effects of adjuvants of H. hemerocallidea, vitamins C and E with HAART on creatinine 
and urea levels in the rats 
Groups BUN (mmol/l) CR-S (µmol/l) 
A 8·07±0·98* 38·67±2·31+ 
B 7·13±1·62* 41·33±1·15+ 
C 6·77±1·95* 38·00±2·00+ 
D 4·66±0·42 23·67±2·08+ 
E 5·27±0·65* 32·33±3·05* 
F 5·86±0·93 30·00±3·00 
G 5·10±1·92* 34·33±1·52+ 
H 6·63±1·03* 34·33±4·04+ 
I 4·90±0·26 30·67±1·52 
Values are expressed as means ±SD of each group. * p<0.05; +p<0.001; BUN is blood urea 
nitrogen; SCR is serum creatinine. 
 
Histopathology of the Kidney 
Histopathological sections of kidneys in control, HAART with vitamin E, and low dose of H. 
hemerocallidea  revealed adequate preservation of tubular structures with normal glomeruli and 
Bowman’s capsule. The interstitial spaces and the urinary space were of normal architecture (figure 
5, 7 and 9).  Animals treated with high dose of H. hemerocallidea showed variable glomerular and 
tubular degenerations varying from; glomerular basement thickening, interstitial inflammation, 
tubular cell swelling and hypercellularity (figure 8). Histopathological sections of kidney treated 
with HAART cocktail also showed cytoarchitectural patterns with extensive necrosis of glomerular 
apparatus with degeneration in the tubules (figure 1). Equally, sections of kidney tissue  treated with 
adjuvant H. hemerocallidea (both doses) showed similar patterns with the HAART group, 
generalized necrosis of renal glomerular corpuscles with many indistinguishable tubules in the  




/atrophic renal tubules (figure 4). Combination of vitamins C and E with HAART (figure 6) resulted 
in many glomeruli congestion with mild to moderate necrosis and interstitial infiltrations. 
 











Fig 1: Photomicrograph of cross section of kidney of 
Sprague-Dawley rats treated with HAART cocktail.  H 
and E stains.  Note the necrosis in glomerulus, atrophied 
proximal convoluted tubules, distal convoluted tubules 
and Bowman’s capsular atrophy. 
 
Fig 2: Photomicrograph of cross section of kidney of 
Sprague-Dawley rats treated with HAART and low dose 
of H. hemerocallidea extract. H and E stains. Note: 
Cellular distortion of glomeruli with atrophy and 
disorganization of proximal convoluted tubules and 





Fig 3: Photomicrograph of cross section of kidney of 
Sprague-Dawley rats treated with HAART and high 
dose of H. hemerocallidea extract. H and E stains. Note: 
Disorganization in proximal & distal cellular 






Fig 4: Photomicrograph of cross section of kidney of 
Sprague-Dawley rats treated with HAART and vitamin 
C. H and E stains. Note: prominent necrosis in the 
glomerulus with deranged Bowman’s capsule and 












         
 
 




Fig 5: Photomicrograph of cross section of kidney of 
Sprague-Dawley rats treated with HAART and vitamin 








Fig 6: Photomicrograph of cross section of kidney of 
Sprague-Dawley rats treated with HAART and vitamin (C 
and E).  H and E stains. Note: Cellular distortion of 











Fig 7: Photomicrograph of cross section of kidney of 
Sprague-Dawley rats treated with low dose of H. 
hemerocallidea extract alone. H and E stains. 










Fig 8: Photomicrograph of cross section of kidney of 
Sprague-Dawley rats treated with high dose of H. 
hemerocallidea extract alone. H and E stains. Note: 
Cellular distortion of glomeruli with derangement of 
Bowman’s capsule and space and atrophy of the 









Fig 9: Photomicrograph of cross section of kidney of 
Sprague-Dawley rats in control group. Showing normal 










The kidney plays an important role in the metabolism and excretion of drugs as well as maintenance 
of constancy in the volume and composition of the extracellular fluid (ECF). Through these 
mechanisms, the basic functions of glomerular filtration, tubular reabsorption and secretions are 
fulfilled (Skalova, 2005) but also predisposes this organ to various types of injuries that may require 
renal replacement therapy (Choi et al., 2009). The animal model of assessment of renal function 
especially using the male rats has proven to be suitable due to the less variability in intra-renal 
enzyme distribution (Raab, 1972).  
As PLWHAs continue to enjoy decreased morbidity and mortality due to HAART, organ toxicities 
(in particular the kidney) are frequently becoming a major concern in view of associated 
consequences that may predispose to hypertensive and /or other metabolic complications (Azu, 
2014). The result of this study showed that animals on HAART as well as adjuvant treatment with 
H. hemerocallidea recorded increased body weight. Similarly, kidney weight was increased in 
HAART treated animals. The reason for this weight gain remains to be explained but it is possible 
that appetite was not affected in the animals by the treatment. However the significant kidney-body 
weight ratio possibly suggests of negative effects on the kidney. Nephrotoxicity may manifest in the 
form of organ swelling and hence increase kidney weight  as seen in the kidney-body weight ratio 
(table 1) which is a sensitive and effective indicator of toxicology and thus important in the 
identification of target organ by toxicants (Asagba et al., 2007).  While daily urinary flow was not 
monitored, it is plausible to adduce that polyuria with consequent loss of water and ions might be 
(in part) responsible for the weight changes of which H. hemerocallidea could not ameliorate.   
Morphological and physiological studies have identified the renal system as site of attack by 
noxious substances/drugs with consequent derangement on the renal histology. More so, 
nephrotoxicity has been identified as a potential flaw with some antiretroviral regimen (especially 
with nevirapine or tenofovir) (Wyatt et al., 2009). Therefore, the aberrations in the glomerular 
histo-architecture in HAART-treated group as well as the inability of adjuvant H. hemerocallidea to 
mitigate the derangements further suggest that the later may not be nephroprotective. This 
observation is supported by the reports of Musabayane et al., (2005) that showed that chronic 
infusion of H.  hemerocallidea extracts may cause a decrease in glomerular filtration rate and 




However, treatment with low dose H.  hemerocallidea alone did not show any damage to the renal 
histoarchitecture and other parameters recorded whereas treatment with high dose H. 
hemerocallidea  showed aberrant histoarchitecture of the kidney with extensive derangements of the 
glomerulus and the renal tubular system. 
Interestingly, result on co-administration of vitamins C and E with HAART does not support (from 
histopathological observations and biochemical markers) the concurrent use of these vitamins as 
supplements by PLWHAs. It is believed that vitamins C and E alter bioavailability, metabolism and 
pharmacokinetics of certain HIV medications raising concerns about the possibility of HAART and 
vitamin supplementation leading to increased toxicity (Nkengfack et al., 2012). While this report 
does not include oxidative stress parameters, there is substantial evidence from in vitro animal 
studies as well as clinical trials recognizing oxidative stress as a major pathway of action for most 
antiretroviral drugs. The consequence is direct cellular attack and mitochondrial DNA depletion or 
direct tubular cytotoxicity (Gallant and Deresinski 2003; Cihlar et al., 2001).  
Biochemical markers play an important role in accurate diagnosis of diseases and also for assessing 
risks and adopting therapies that may improve clinical outcome. Over decades research and 
utilization of biomarkers have evolved substantially. As markers of renal function, serum creatinine 
(SCR) and blood urea nitrogen (BUN) routinely serve as indicators for normal biological, 
pathologic processes, or pharmacologic responses to a therapeutic intervention. The present study 
revealed that administration of HAART caused marked impairment in renal function. SCR and 
BUN concentrations were significantly higher in HAART-treated rats and this is consistent with 
lower creatinine and BUN clearance. In addition, elevated level of SCR and BUN concentrations 
might have resulted from remarkable leakage due to hypercellularity of the glomeruli and tubules.  
It is speculated that the capacity for glomerular filtration and tubular absorption may have been 
altered, thus bringing about functional overload of nephrons with subsequent renal dysfunction.  
Interestingly, the administration of HAART and H.  hemerocallidea concomitantly did not improve 
the SCR and BUN clearance in this protocol. It is possible that drug-drug interactions between H. 
hemerocallidea and HAART that could affect efficacy or safety of the later is possible. Mills and 
his team (2005) showed that interactions between extracts of H.  hemerocallidea and antiretroviral 
drugs inhibit CYP3A4, an isoform of cytochrome P450 and drug transporter protein (P-
glycoprotein). In addition, H.  hemerocallidea extracts have been claimed to activate drug nuclear 




(Mills et al., 2005). Many antiretroviral drugs are substrate of CYP3A4 and some herbal 
preparations are known to alter blood levels of these drugs through their effects on CYP3A4 and p-
glycoprotein (Mills et al., 2005). It is therefore reasonable to argue that H. hemerocallidea could 
potentially interact with HIV drug- metabolizing enzymes thus patients taking H.  hemerocallidea 
extracts concurrently with antiretroviral drugs, may be at risk of developing adverse effects which 
may lead to treatment failure, viral resistance and/ or drug toxicity. 
Conclusion  
While HAART continues to be the cornerstone in the management of HIV/AIDS in sub-Saharan 
Africa, the complex issues of toxicities, resistance as well as drug interactions would continue to be 
an impediment to achieving the desirable goals. It has emerged from this study that renal 
derangements based on the histological and biochemical assessments were seen following HAART 
and these were not mitigated by H. hemerocallidea adjuvants and therefore draws to caution the 
concomitant use of H. hemerocallidea extracts by PLWHAs in the sub-region. However, because H. 
hemerocallidea may contain several other constituents which are yet to be isolated apart from 
rooperol, hypoxoxide, lectins and phytosterols, there is need for further investigation in this 
direction. 
Acknowledgement 
We thank the College of Health Sciences, University of KwaZulu-Natal Durban South Africa for 
the postgraduate financial support awarded to the second author and the National Research 
Foundation of South Africa for the grant, Unique No. 94018 awarded to the senior author. 
References 
Abrescia N, D'Abbraccio M, Figoni M, Busto A, Maddaloni A and De Marco M, (2005). 
Hepatotoxicity of antiretroviral drugs. Current Pharmaceutical Design. Review. 11(28): 3697-3710.  
Albrecht C.F, Theron E.J and Kruger P.B, (1995). Morphological characterization of the cell growth 
inhibitory activity of rooperol and pharmacokinetic aspects of hypoxoside as an oral prodrug for 
cancer therapy. S. Afri Med Journal 85:853-860. 
Asagba S.O, Adaikpoh M.A, Kadiri H and Obi FO, (2007). Influence of aqueous extract of Hibiscus 




Awad A.B and Fink C.S, (2000). Phytosterols as anticancer dietary components: evidence and 
mechanism of action. J. Nutri 130: 2127-2130. 
Azu O.O, (2012). Highly Active Antiretroviral Therapy (HAART) and testicular morphology: 
current status and a case for stereological approach. J. Androl 33: 1130-1142. 
Azu O.O, (2012). Highly Active Antiretroviral Therapy (HAART) and testicular morphology: 
current status and a case for stereological approach. J. Androl 33: 1130-1142. 
Bodeker G, Carter G, Burford G and Dvorak-Little M, (2006).  HIV/AIDS:  Traditional Systems of 
Health Care in the Management of a Global Epidemic.  J.  Altern Complement Med. 12(6): 63-76. 
Choi A.I, Shlipak M.G, Hunt P.W, Martin J.N and Deeks S.G, (2009). “HIV-infected persons 
continue to lose kidney function despite successful antiretroviral therapy,” AIDS, 23(16): 2143–
2149. 
Cihlar T, Ho E.S, Lin D.C and Mulato A.S, (2001). Human renal organic anion transporter 1 
(hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs. Nucleosides Nucleotides 
Nucleic Acids, 20: 641-648. 
Drewes S.E, Elliot E, Khan F, Dhlamini J.T.B and Gcumisa M.S.S (2008). Hypoxis hemerocallidea 
not merely a cure for benign prostate hyperplasia. J. Ethnopharmacol 119: 593-598. 
Fabian A and Germishuizen G, (1997). Wild flowers of Northern South Africa. Fernwood press 
Vlaeburg. 285. 
Gallant J.E and Deresinski S, (2003). “Tenofovir disoproxil fumarate,” Clinical Infectious Dis. 
37(7): 944– 950. 
Ker J, (2005). Ventricular tachycardia as an adverse effect of the African potato (Hypoxis Spp). 
Cardiovasc J.S. Afr 16: 55. 
Laporta O, Perez-Fons L, Mallavia R, Caturla N and Micol V, (2007). Isolation, characterization 
and antioxidant capacity assessment of the bioactive compounds derived from Hypoxis rooperi 




Mills E, Cooper C, Seely D and Kanfer I, (2005). African herbal medicines in the treatment of HIV: 
Hypoxis and sunderlandia. An overview of evidence and pharmacology. Nutrition Journal 4:19. 
Moreau R.A., Bruce D.W. and Kevin B.H. (2002). Phytosterols, phytostanols, and their conjugates 
in foods: structural diversity, quantitative analysis, and health-promoting uses. Prog. Lipid Res. 41, 
457–500. 
Musabayane C.T, Xozwa K and Ojewole J.A.O, (2005). Effects of Hypoxis hemerocallidea (Fisch 
& C.A. Mey) (Hypoxidaceae) corm (African potato) aqueous extract on renal electrolyte and fluid 
handling in the rat. Renal failure 2: 763-770. 
Nair V.D.P and Kanfer I, (2007). A capillary zone electrophoresis method for the quantitative 
determination of hypoxoside in commercial formulations of African potato (Hypoxis 
hemerocallidea). Phytochem. Anal. 18: 475-483. 
National institutes of Health Guide for the care and use of Laboratory Animals. DHEW Publication 
(NIH) (1985): Revised, Office of Science and Health Reports, DRR/NIH, Bethseda; USA. 
Ncube B, Finnie J.F, and van Staden J, (2011). Seasonal variation in antimicrobial and 
phytochemical properties of frequently used medicinal bulbous plants from South Africa. S. Afr. J. 
Bot.77: 387-396. 
Nkengfack G.N, Torimiro J.N, and Englert H, (2012). Effects of antioxidants on CD4 and viral load 
in HIV-infected women in sub-Saharan Africa—Dietary supplements vs. local diet. Int. J. Vitam. 
Nutr. Res. 82: 63–72. 
Ojewole J.A.O, Olayiwola G and Nyinawumuntu A, (2009). Bronchorelaxant property of ‘African 
potato’ (Hypoxis hemerocallidea corm) aqueous extract in vitro. J. smooth muscles research 45: 
241-248. 
Ojewole J.A.O, Kamadyaapa D.R and Musabayane C.T, (2006). Some in vitro and in vivo 
cardiovascular effects of Hypoxis hemerocallidea Fisch & C.A. Mey (Hypoxidaceae) corm (African 




Owira P.M.O and Ojewole A.O, (2009). ‘African potato’ (Hypoxis hemerocallidea corm): a plant 
medicine for modern and 21st century diseases of mankind? A review. Phytotherapy Research 23: 
147-152. 
Perazella M.A, (2010). “Tenofovir-induced kidney disease: an acquired renal tubular 
mitochondriopathy,” Kidney International. 78(11):1060–1063. 
Raab W.P, (1972). Kaliopenic nephrosis: protective action of l-ornithine-l-aspartate. Clinica 
Chimica Acta. 39 (1): 239-242.  
Skalova S, (2005). The diagnostic role of urinary N-acetyl-b-glucosaminidase (NAG) activity in the 
detection of renal tubular impairment. Acta Medica.48:75-80. 
Soriano V, Puoti M, Garcia-Garsco P, Rockstroh J.K, Benhamou Y, Barreiro P and McGovern B, 
(2008). Antiretroviral drugs and liver injury. AIDS.22:1–13. 
Sattler F.R, Qian D, Louie S, Johnson D, Briggs W, DeQuattro V and Dube M.P, (2001). Elevated 
blood pressure in subjects with lipodystrophy. AIDS 15, 2001–2010. 
Steenkamp V, Gouws M.C, Gulumian M, Elgorashi E.E and van Staden J, (2006). Studies on 
antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of 
benign prostrate hyperplasia and prostatitis. J. Ethnopharmacol. 103: 71-75. 
Van Wyk B.E (2008). A broad review of commercially important South African medicinal plants. J. 
Ethnopharmacology 119: 342-355. 
Walker U, Bauerle J, Laguno M, Murillas J, Mauss S, Schmutz G, Setzer B, Miquel R, Gatell J.M 
and Mallolas J, (2004). Deletion of mitochondrial DNA in liver under antiretroviral therapy with 
didanosine, stavudine or zalcitabine. Hepatology. 39:311–317. 
Wyatt C. M., Morgello S and Katz-Malamed R, (2009). The spectrum of kidney disease in patients 







SYNTHESIS, CONCLUSION AND RECOMMENDATION 
3.1      Synthesis 
There is no doubt that HAART has been the most important progress in the management of HIV-
infected patients in the last decade. A number of observations suggest that the beneficial effects of 
HAART include lowering the viral load of HIV-infected patients by generally targeting reverse 
transcription of viral RNA into cDNA and hence, their positive impact on longevity. However, the 
growing population of patients treated with HAART requires the consideration of potential renal 
side effects that may accompany the use of HAART.  
Histological studies are important in renal localization of the toxic or beneficial actions of various 
drugs. In this study, the histological parameters of the HAART cocktail present a compromised 
histological state with extensive necrosis of the glomeruli, tubular toxicity as well as atrophy of the 
Bowman’s capsule and space. The observation of the toxicity of HAART are in tandem with reports 
by other authors who reported deleterious histological changes following HAART on the testicular 
tissue linked to the damage of the mitochondrial apparatus (Azu et al., 2014). 
Therefore, it is tempting to speculate that the toxicity of HAART in the renal localization is due to 
mitochondrial cytopathy. Several studies of HAART renal toxicity argue in favour of such 
hypothesis (Kakuda et al., 2000). 
Firstly, among recognized adverse effects of HAART, mitochondrial toxicity as well as damage 
indicated by histological features in the kidney is induced by members of NRTIs family (Kakuda et 
al., 2000). To a greater or lesser degree, all are responsible for proximal tubular cell toxicity that 
clinically manifest as proximal tubular dysfunction. Therefore it is tempting to make a link between 
the tubular cell toxicity and mitochondrial toxicity of HAART. 
Secondly, HAART-treated patients often present with renal failure clinically and histologically 
related to tubulointerstitial nephropathy and associated with extra-renal manifestations attributable 
to mitochondrial cytopathy (Coca and Perazella, 2002). 
Thirdly, intracellular droplets-like lipids are present in proximal tubular cells of patients with renal 




lipid droplets are characteristic of unused fatty acids in cells with defective mitochondria (Kakuda 
et al., 2000). 
Finally, the “mitochondrial cytopathy hypothesis” was invoked to explain adefovir and stavudine 
nephrotoxicity by Tanji et al., 2001 who reported a patient with degenerative changes in proximal 
tubules and renal tubular cells with dysmorphic mitochondria and mitochondria DNA depletion. 
Adjuvant treatment with H. hemerocallidea and HAART in both doses showed deleterious 
histological changes of the kidney. This possibly could suggest drug-drug interactions. Drug and 
traditional medicine (TM) interactions occur when a TM and orthodox medicine influence the 
effects of each other. This may cause a change in pharmacodynamics and / or pharmacokinetic 
parameters which may affect efficacy or safety of either orthodox medicine or TM. (Mills et al., 
2005). Potential drug interactions between extracts of H. hemerocallidea and antiretroviral drugs 
have been reported to inhibit CYP3A4 isoform of cytochrome P450 and drug transporter protein (P-
glycoprotein). Patients taking H. hemerocallidea concurrently with antiretroviral drugs, may 
therefore, be at risk of developing adverse effects which may lead to treatment failure. 
Treatment with high dose of H. hemerocallidea showed aberrant histoarchitecture of the kidney 
with extensive derangements of the glomerulus and the renal tubular system whereas treatment with 
low dose of H. hemerocallidea did not show any damage to the renal histoarchitecture whereupon, 
the remarkable renal indices where intact. 
The use of vitamins C and E as antioxidant supplements in ART has been practiced both in 
experimental and clinical conditions because they are believed to scavenge free radicals. However, 
vitamins C and E (combined) did not show any improvement of the kidney from the various 
parameters assessed. Treatment with vitamin E alone shows essentially normal histological 
appearance while vitamin C did not show any improvement in renal histoarchitecture further raising 
concerns about the possibility of HAART and vitamin supplementation leading to increased 
toxicity. 
Although this report does not include oxidative stress parameters, evidence from literatures 
recognizes oxidative stress as a major pathway of action for most antiretroviral drugs. Oxidative 
stress can also promote the formation of a variety of vasoactive mediators that can affect renal 
function directly by initiating renal vasoconstriction or decreasing the glomerular capillary 
ultrafiltration coefficient; and thus reducing glomerular filtration rate (GFR) (Garcia Cohen et al., 




accumulation of various nitrogenous waste products in the plasma and other body fluids (Garcia 
Cohen et al., 2000). The present study revealed that administration of HAART caused marked 
impairment in renal function. SCR and BUN concentrations were significantly higher in HAART 
treated rats and this is consistent with lower creatinine and BUN clearance. 
Weight coefficient (organ/BW ratio) is a sensitive and effective indicator of toxicology and thus 
important in the identification of target organ by toxicants (Asagba et al., 2007). The study revealed 
that the weight coefficient of kidney tissue in HAART- treated animals was significantly higher 
than those of controls, further supporting the toxicity of HAART to this organ. 
3.2     Conclusion 
HAART has dramatically improved survival in PLWHAs. However, precautions should be taken to 
prevent HAART-related nephrotoxicity or systemic life-threatening side-effects whose risk may be 
increased by renal failure. The study highlighted that treatment with H. hemerocallidea in 
preventing renal toxicity following HAART led to more deleterious changes in the histoarchitecture 
of the kidney. From the study, H. hemerocallidea and HAART may not be taken together in the 
face of kidney life- threatening situations following HAART, and thereby putting the patients on the 
horns of more dilemmas. From available folkloric, anecdotal and laboratory evidence, H. 
hemerocallidea extracts contain some chemical compounds with anti-inflammatory, antidiabetic 
and antioxidant activities. They may also contain several other constituents which are yet to be 
isolated. It is possible that these chemical compounds of H. hemerocallidea extract act together with 
other compounds yet to be isolated. Certainly, more laboratory and clinical studies are required to 
clarify this situation. 
3.3     Recommendations 
In view of the findings of this research on nephrotoxicity of HAART regimen, it is believed that the 
occurrence of renal derangements are prevalent, HIV patients who are clinically and virologically 
stable should continue with HAART unless severe or complex complications emerge. If they occur, 
adequate treatment options for the adverse events are prescribed like regimen change, temporary 
withdrawal or complete stoppage after a thorough clinical evaluation. 
Secondly, in view of the possible drug-drug interactions likely between AP and HAART regimen, it 




protocol and detailed pharmacokinetic properties thereof. This in addition to other investigational 
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